Preclinical development of antisense conjugates for the treatment of myotonic dystrophy 1
<p>Myotonic dystrophy type 1 (DM1) is a complex autosomal dominant neuromuscular disorder that affects approximately 1 in 8,000 individuals. DM1 impacts multiple organ systems, including skeletal muscle, heart and central nervous system (CNS), leading to a diverse range of symptoms. Despite on...
| Үндсэн зохиолч: | |
|---|---|
| Бусад зохиолчид: | |
| Формат: | Дипломын ажил |
| Хэл сонгох: | English |
| Хэвлэсэн: |
2024
|
| Нөхцлүүд: |